TG Therapeutics, Inc. (TGTX): Price and Financial Metrics
TGTX Price/Volume Stats
| Current price | $40.79 | 52-week high | $43.32 |
| Prev. close | $42.80 | 52-week low | $12.93 |
| Day low | $40.31 | Volume | 2,326,400 |
| Day high | $42.92 | Avg. volume | 2,682,293 |
| 50-day MA | $33.94 | Dividend yield | N/A |
| 200-day MA | $26.95 | Market Cap | 6.41B |
TGTX Stock Price Chart Interactive Chart >
TG Therapeutics, Inc. (TGTX) Company Bio
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company was founded in 1993 and is based in New York, New York.
TGTX Price Returns
| 1-mo | 40.56% |
| 3-mo | 21.76% |
| 6-mo | 71.17% |
| 1-year | 164.18% |
| 3-year | 309.13% |
| 5-year | 314.95% |
| YTD | 35.51% |
| 2024 | 76.23% |
| 2023 | 44.38% |
| 2022 | -37.74% |
| 2021 | -63.48% |
| 2020 | 368.65% |
Continue Researching TGTX
Want to see what other sources are saying about Tg Therapeutics Inc's financials and stock price? Try the links below:Tg Therapeutics Inc (TGTX) Stock Price | Nasdaq
Tg Therapeutics Inc (TGTX) Stock Quote, History and News - Yahoo Finance
Tg Therapeutics Inc (TGTX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...